BRCA1/2-negative, High-Risk Breast Cancers (BRCAX) for Asian Women: Genetic Susceptibility Loci and Their Potential Impacts

Scientific Reports - United Kingdom
doi 10.1038/s41598-018-31859-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

BRCA1/2-negative Hereditary Triple-Negative Breast Cancers Exhibit BRCAness

International Journal of Cancer
Cancer ResearchOncology
2017English

Reanalysis of BRCA1/2 Negative High Risk Ovarian Cancer Patients Reveals Novel Germline Risk Loci and Insights Into Missing Heritability

PLoS ONE
Multidisciplinary
2017English

High Prevalence of Preinvasive Lesions Adjacent to BRCA1/2-Associated Breast Cancers

Cancer Prevention Research
MedicineCancer ResearchOncology
2009English

BRCA1-IRIS Inactivation Overcomes Paclitaxel Resistance in Triple Negative Breast Cancers

Breast Cancer Research
Cancer ResearchOncology
2015English

Increased Proliferative Background in Healthy Women With BRCA1/2 Haploinsufficiency Is Associated With High Risk for Breast Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2013English

Triple-Negative Versus Non-Triple-Negative Breast Cancers in High-Risk Women: Phenotype Features and Survival From the HIBCRIT-1 MRI-Including Screening Study

Clinical Cancer Research
Cancer ResearchOncology
2015English

53BP1 Loss Rescues BRCA1 Deficiency and Is Associated With Triple-Negative and BRCA-mutated Breast Cancers

Nature Structural and Molecular Biology
Structural BiologyMolecular Biology
2010English

Elucidating Therapeutic Molecular Targets in Premenopausal Asian Women With Recurrent Breast Cancers

npj Breast Cancer
OncologyRadiologyNuclear MedicinePharmacologyImaging
2018English

Phenotypic Analysis of Familial Breast Cancer: Comparison of BRCAx Tumors With BRCA1-, BRCA2-carriers and Non-Familial Breast Cancer

European Journal of Surgical Oncology
MedicineOncologySurgery
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy